Sign In
Buy LLY
$1,185.71
-7.09 (-0.594%)
At Close: Aug 07, 2026
JNJ, LLY: Health Care Earnings To Watch
01:08pm, Friday, 26'th Jan 2024
Eli Lilly (LLY) is up over 80% year-over-year. Lee Brown discusses health care stocks.
El Lilly surpasses Tesla's market size: why has the biotech stock become so attractive?
06:46am, Friday, 26'th Jan 2024
Barely four years ago, El Lilly (NYSE:LLY) was trading at just around $130. Fast forward, the stock trades at a whopping $627, having recently rubbed a new record price above $645.
Eli Lilly's Wegovy rival Mounjaro gets UK green light
04:28am, Friday, 26'th Jan 2024
Mounjaro, Eli Lilly's (NYSE:LLY) rival weightloss drug to Wegovy and Ozempic, is to be made available in the UK after receiving the regulatory green light. The UK Medicines and Healthcare products Re
British regulator clears Lilly's injection pen for weight-loss drug Mounjaro
11:54am, Thursday, 25'th Jan 2024
Britain's drug regulator on Thursday said it approved Eli Lilly's injection pen to administer the drug Mounjaro against obesity and diabetes.
5 top healthcare stocks for earnings growth in 2024
07:09am, Thursday, 25'th Jan 2024
Sector components forecast to show the biggest earnings year-over-year earnings improvement include Humana Inc. NYSE: HUM, Elevance Health Inc. NYSE: ELV, Incyte Corp. NASDAQ: INCY, Insulet Corp.
Lilly's Mounjaro dose in limited availability in US through next month
11:47am, Wednesday, 24'th Jan 2024
A dose of Eli Lilly's diabetes drug Mounjaro has limited availability through February 2024, according to the U.S. Food and Drug Administration's website, due to an increase in demand.
Eli Lilly (LLY) Stock Sinks As Market Gains: Here's Why
06:50pm, Tuesday, 23'rd Jan 2024
The latest trading day saw Eli Lilly (LLY) settling at $629.68, representing a -0.19% change from its previous close.
Eli Lilly gene therapy allows child born deaf to hear, clinical trial shows
01:06pm, Tuesday, 23'rd Jan 2024
An Eli Lilly & Co. LLY, -0.47% experimental gene therapy has restored the hearing of a child who was born deaf, the pharmaceutical giant said Tuesday.
These 2 Growth Stocks Are Brilliant Buys for the New Year
09:45am, Tuesday, 23'rd Jan 2024
The healthcare industry has long been a compelling space for investors to generate steady returns. DexCom is raking in profits from newly launched products, and its long-term growth story looks bright
Don't Be Fooled by These 3 Misleading Facts About Eli Lilly Stock
01:59am, Tuesday, 23'rd Jan 2024
Eli Lilly has a lot of debt, but it's to help expand its manufacturing capacity. It doesn't appear to have much cash, but that's because of investments in R&D.
Cramer taps Eli Lilly as a new member of the 'Magnificent Seven' if Tesla earnings falter
07:19pm, Monday, 22'nd Jan 2024
CNBC's Jim Cramer said Tesla may have hit a "growth pause," compared to its Big Tech peers that are still on the rise.
This pharma stock is gearing up for a huge surge
07:31am, Monday, 22'nd Jan 2024
After years of a slowdown in performance and revenue, Eli Lilly (NYSE: LLY) is starting to turn the page. With its innovations in the pharmaceutical sector, most notably in diabetes treatment, its med
Prediction: This Will Be the First Trillion-Dollar Healthcare Stock
11:02am, Sunday, 21'st Jan 2024
Eli Lilly is the largest healthcare company by market capitalization. The company is unlikely to underperform its similarly-sized peers.
Is It Too Late to Buy Eli Lilly Stock?
10:30am, Sunday, 21'st Jan 2024
Eli Lilly's stock has been soaring due to the excitement around Zepbound. The stock's high valuation, however, could be a concern for value-oriented investors.
Here's What Investors Should Expect From Eli Lilly Stock in 2024
04:29pm, Saturday, 20'th Jan 2024
Eli Lilly just wrapped up a great year for shareholders, and there may be an encore in 2024. The company is going to continue its business development bonanza.
